| 07/23/2026 15:30 |
Notice Regarding Completion of Payment for Disposition of Treasury Shares as Restricted Stock Compensation |
| 06/25/2026 15:30 |
Notice Regarding Disposition of Treasury Shares as Restricted Stock Compensation |
| 06/25/2026 13:30 |
Corporate Governance Report |
| 06/22/2026 15:30 |
Notice of Establishment of a New Company, ExaForward Kyushu Inc. |
| 06/09/2026 15:30 |
Notice of Establishment of a New Company, Exa Interaction Design Lab Inc |
| 06/03/2026 08:00 |
Notice of Convocation of the 11th Annual Shareholders' Meeting |
| 05/22/2026 15:30 |
Notice Regarding Introduction of Restricted Stock Awards Plan |
| 05/22/2026 15:30 |
Notice Regarding the Establishment of a Joint Venture with the MS&AD Group |
| 05/21/2026 14:30 |
Regarding Certain Media Reports |
| 05/12/2026 15:30 |
Notice Concerning Change in Shareholder Return Policy |
| 05/12/2026 15:30 |
Notice Concerning Reorganization of the Nursing Care Business Through Intra-Group Merger and Company Split |
| 05/12/2026 15:30 |
Notice Concerning Recognition of Deferred Tax Assets, Extraordinary Loss (Impairment Loss), and Year-on-Year Differences in Financial Results |
| 05/12/2026 15:30 |
Financial Results for the Fiscal Year Ended March 2026 |
| 05/12/2026 15:30 |
Consolidated Financial Results for the Fiscal Year ended March, 2026 |
| 03/31/2026 15:45 |
Notice Regarding Planned Change in Major Shareholders and Largest Major Shareholder |
| 03/31/2026 15:45 |
Announcement of Capital and Business Alliance Agreement and Notice of the Disposition of Treasury Shares via Third-Party Allotment |
| 03/26/2026 08:30 |
Announcement of Changes in Management Team |
| 03/12/2026 16:45 |
Notice of Establishment of a New Company, Exa Frontier Edge Inc. |
| 03/12/2026 16:45 |
Notice of Revision to Full-Year Consolidated Earnings Forecast (Upward Revision) |
| 02/12/2026 15:30 |
Notice Regarding Transfer of Business through Company Split |
| 02/12/2026 15:30 |
Financial Results for the Third Quarter of FY2026 |
| 02/12/2026 15:30 |
Consolidated Financial Results for the Nine Months Ended December 31, 2025 |
| 02/05/2026 08:30 |
Notice Regarding Clinical Trial Notification Submission by Subsidiary for AI-Powered Cognitive Function Diagnostic Support Application (SaMD) |
| 02/02/2026 15:30 |
ExaWizards to Provide Comprehensive Support for the Kansai Transmission and Distribution DX Strategy 2026 |
| 01/30/2026 08:40 |
ExaWizards and Dirbato Announce Business Alliance to Accelerate Corporate AX and AI Agent Utilization |
| 11/11/2025 15:30 |
Financial Results for the Second Quarter of FY2026.3 |
| 11/11/2025 15:30 |
Notice of Revision to Full-Year Consolidated Earnings Forecast (Upward Revision) and Recording of Deferred Income Taxes |
| 11/11/2025 15:30 |
Consolidated Financial Results for the Six Months Ended September 30, 2025 |
| 09/30/2025 15:30 |
Launch of AI Product "exaBase Empower" to Support HR Data Analysis and Strategic HR Planning |
| 08/19/2025 08:40 |
ExaWizards Launches AX Training Programs to Develop AI Talent For All Employees, from Management to New Graduates |
| 08/12/2025 15:30 |
Financial Results for the First Quarter for FY2026.3 |
| 08/12/2025 15:30 |
Notice Regarding Continuation of ESOP Trust |
| 08/12/2025 15:30 |
Notice Regarding Change in Reportable Segments |
| 08/12/2025 15:30 |
Consolidated Financial Results for the Three Months Ended June 31, 2025 |
| 08/08/2025 15:31 |
Notice Regarding Determination of Terms for Issuance of Stock Options |
